Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Researchers have shown that differences in the entire rotavirus genome—not just its two surface proteins—affect how well ...

An international team of researchers co-led by Job Dekker, Ph.D., at UMass Chan Medical School, have identified rules that tell cells how to fold DNA into the tightly packed, iconic X-shaped ...

Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with ...

Apr. 8, 2025 — A new study maps how specific lactic acid bacteria can enhance both the flavor and nutritional quality of plant-based dairy alternatives. The findings may have wide-reaching ...

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Antivirus apps protect your PC's personal information, data, bank accounts, and much more. We've tested more than two dozen utilities to help you choose the best antivirus for your needs. When the ...

Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...

A cladogram representative of faecal microbial structure and their predominant bacteria displayed the greatest differences in taxa between liver cirrhosis and early HCC (all p<0.05, online ...